
Medartis announced a favorable first clinical use of its Lapidus Cut Guide. The instrument is one of several new lower extremity products scheduled for launch in the U.S. this year.
The single-use Lapidus Cut Guide system is an instrumentation-only system designed to provide an anatomically intuitive resection of the first tarsometatarsal joint (TMT) in preparation for a Lapidus procedure which aims to surgically treat a bunion deformity caused by TMT joint hypermobility.
The cut guide allows the surgeon to resect both sides of the joint, potentially helping reduce the risk of unnecessary shortening of the first metatarsal while providing an unconstrained angle correction. The flexibility of the design allows surgeons to tailor the resection to meet the unique requirements of the patient’s anatomy.
“We’re excited about the initial results from our first product launched under the Medartis banner,” Ryan Schlotterback, Chief Technology Officer (U.S.) for Medartis, said. “The fully sterile, disposable Lapidus Cut Guide system is designed to be simple and intuitive, allowing the surgeon to make corrective cuts to both the metatarsal and cuneiform. This product complements the APTUS plate and screw technology of the Medartis portfolio.”
Nextremity Solutions, a fully-owned subsidiary of Medartis, is the legal manufacturer of the Lapidus Cut Guide.
Source: Medartis Inc.
Medartis announced a favorable first clinical use of its Lapidus Cut Guide. The instrument is one of several new lower extremity products scheduled for launch in the U.S. this year.
The single-use Lapidus Cut Guide system is an instrumentation-only system designed to provide an anatomically intuitive resection of the first tarsometatarsal joint...
Medartis announced a favorable first clinical use of its Lapidus Cut Guide. The instrument is one of several new lower extremity products scheduled for launch in the U.S. this year.
The single-use Lapidus Cut Guide system is an instrumentation-only system designed to provide an anatomically intuitive resection of the first tarsometatarsal joint (TMT) in preparation for a Lapidus procedure which aims to surgically treat a bunion deformity caused by TMT joint hypermobility.
The cut guide allows the surgeon to resect both sides of the joint, potentially helping reduce the risk of unnecessary shortening of the first metatarsal while providing an unconstrained angle correction. The flexibility of the design allows surgeons to tailor the resection to meet the unique requirements of the patient’s anatomy.
“We’re excited about the initial results from our first product launched under the Medartis banner,” Ryan Schlotterback, Chief Technology Officer (U.S.) for Medartis, said. “The fully sterile, disposable Lapidus Cut Guide system is designed to be simple and intuitive, allowing the surgeon to make corrective cuts to both the metatarsal and cuneiform. This product complements the APTUS plate and screw technology of the Medartis portfolio.”
Nextremity Solutions, a fully-owned subsidiary of Medartis, is the legal manufacturer of the Lapidus Cut Guide.
Source: Medartis Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.